An interdisciplinary collaboration 10 years in the making used a materials science approach to "fingerprint" the calcium mineral deposits known as microcalcifications that reveal pathological clues to the progression of breast ...
Feb 22, 2023
0
64
A novel nuclear medicine imaging protocol can take the place of two separate imaging scans for the evaluation of brain changes linked to cognitive impairment, cutting costs and radiation exposure for patients as well as providing ...
Feb 8, 2023
0
15
Lecanemab: It's an experimental medication that's been shown in trials to slow cognitive decline in people with Alzheimer's disease.
Jan 6, 2023
0
6
A new study has determined that approximately three percent of all bone scan patients have markers of cardiac amyloidosis, which can lead to heart failure and increased mortality. Published in The Journal of Nuclear Medicine, ...
Jan 3, 2023
0
2
Two people have now died from brain hemorrhages that may be linked to an experimental Alzheimer's drug, calling into question the medication's safety.
Nov 29, 2022
0
34
Patients with a specific form of age-related macular degeneration (AMD), a leading cause of blindness in the United States, are also highly likely to have either underlying heart damage from heart failure and heart attacks, ...
Nov 17, 2022
0
1228
Scleroderma, also known as systemic sclerosis, is a group of rare diseases that involve the hardening and tightening of the skin. It also may cause problems in the blood vessels, internal organs and digestive tract.
Nov 10, 2022
0
15
Columbia researchers have found a link between a common back ailment and a type of heart failure, suggesting that screening patients with lumbar spinal stenosis could identify those at risk of the heart disease and prevent ...
Aug 31, 2022
0
93
Motion analysis of video recorded on a smartphone accurately detected narrowed arteries in the neck, which are a risk factor for stroke, according to new research published today in the Journal of the American Heart Association, ...
Aug 17, 2022
0
590
Most drugs developed to treat Alzheimer's disease have for years been ineffective in clinical trials. Researchers from Indiana University School of Medicine recently evaluated the efficacy of a failed clinical trial drug ...
Jul 25, 2022
0
15
